Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells
|
journal
|
April 2009 |
Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma
|
journal
|
January 2018 |
Involvement of Glutathione Depletion in Selective Cytotoxicity of Oridonin to p53-Mutant Esophageal Squamous Carcinoma Cells
|
journal
|
January 2020 |
SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism
|
journal
|
July 2018 |
Gluconeogenesis in cancer cells – Repurposing of a starvation-induced metabolic pathway?
|
journal
|
August 2019 |
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
|
journal
|
June 2018 |
The Effects of Severe Hypoxia on Glycolytic Flux and Enzyme Activity in a Model of Solid Tumors: E FFECTS OF A NOXIA ON G LYCOLYSIS IN C ANCER
|
journal
|
February 2016 |
Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway
|
journal
|
January 2018 |
Triggering Fbw7-Mediated Proteasomal Degradation of c-Myc by Oridonin Induces Cell Growth Inhibition and Apoptosis
|
journal
|
March 2012 |
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth
|
journal
|
November 2015 |
Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells
|
journal
|
February 2017 |
Metabolic pathways promoting cancer cell survival and growth
|
journal
|
March 2015 |
Antitumor activity of the isodon diterpenoids: Structural requirements for the activity
|
journal
|
February 1976 |
A Metal‐Organic Framework (MOF) Fenton Nanoagent‐Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition
|
journal
|
March 2020 |
Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma
|
journal
|
February 2015 |
Cancer statistics in China, 2015: Cancer Statistics in China, 2015
|
journal
|
January 2016 |
Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2
|
journal
|
January 2016 |
Oridonin‐induced mitochondria‐dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways
|
journal
|
September 2018 |
Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma
|
journal
|
February 2017 |
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
|
journal
|
March 2019 |
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
|
journal
|
September 2018 |
Glioblastoma and Other Malignant Gliomas: A Clinical Review
|
journal
|
November 2013 |
Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases
|
journal
|
January 2017 |
Oridonin inhibits hypoxia-induced epithelial–mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer
|
journal
|
January 2019 |
Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) Is a Pro-survival, Endoplasmic Reticulum (ER) Stress Response Gene Involved in Tumor Cell Adaptation to Nutrient Availability
|
journal
|
August 2014 |
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
|
journal
|
October 2018 |
Autophagy maintains tumour growth through circulating arginine
|
journal
|
November 2018 |
Hallmarks of Cancer: The Next Generation
|
journal
|
March 2011 |
Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells
|
journal
|
August 2019 |
Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors
|
journal
|
February 2015 |
Targeting autophagy in cancer: Targeting Autophagy in Cancer
|
journal
|
April 2018 |
Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells
|
journal
|
April 2016 |
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer
|
journal
|
March 2014 |
Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells
|
journal
|
September 2019 |
Autophagy and multidrug resistance in cancer
|
journal
|
June 2017 |
Cancer statistics, 2018: Cancer Statistics, 2018
|
journal
|
January 2018 |
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|
journal
|
February 2019 |
SnapShot: Cancer Metabolism Pathways
|
journal
|
March 2013 |
Expression of phosphoenolpyruvate carboxykinase linked to chemoradiation susceptibility of human colon cancer cells
|
journal
|
March 2014 |
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth
|
journal
|
October 2015 |
PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis
|
journal
|
February 2019 |
Dexamethasone inhibits the proliferation of tumor cells
|
journal
|
January 2019 |
Oridonin attenuates carrageenan-induced pleurisy via activation of the KEAP-1/Nrf2 pathway and inhibition of the TXNIP/NLRP3 and NF-κB pathway in mice
|
journal
|
September 2019 |